ESTRO 36 Programme book and exhibition guide

SATURDAY 6 MAY 2017

SCIENTIFIC PROGRAMME

| Programme and Exhibition Guide

tumor heterogeneity in the field of radiation oncology. One solution is the use of

brachytherapy for the so-called ‘ dose-painting’. Because of the high dose gradients

of brachytherapy dose distribution, separate areas can effectively be treated distinctly.

Combination therapy approaches and focal therapies are thus key strategies to address

this heterogeneity.

Chair: B. Pieters (The Netherlands)

Co-chair: K. Kapp (Austria)

14:45 > Using heterogeneous brachytherapy dose distributions to target tumour

cell heterogeneity

R. Alonzi (UK)

SP-0101

15:03 > MRI assisted focal boost integrated with HDR monotherapy for low/

intermediate risk prostate cancer

L. Dalimonte (Canada), J. Helou, G. Morton, H. Chung, M. McGuffin,

A. Ravi, A. Loblaw

OC-0102

15:13 > The challenges of targeting tumour heterogeneity in the field of radiation

oncology

P. Lambin (The Netherlands)

SP-0103

15:31 > The impact of tumour heterogeneity on radiation therapy outcomes

M. Gerlinger (UK)

SP-0104

15:49 > Hybrid F-MISO PET/MRI for radiation therapy response assessment in

cervix cancer

M. Daniel (Austria), P. Andrzejewski, A. Sturdza, K. Majercakova,

P. Baltzer, K. Pinker, W. Wadsak, R. Pötter, T. Hellbich, P. Georg, D. Georg

OC-0105

SYMPOSIUM

Innovations in ion beam therapy

14:45 - 16:00 | STRAUS 2-3

Chair: L.P. Muren (Denmark)

Co-chair: M. Navratil (Czech Republic)

14:45 > Reducing range uncertainties: new approaches for stopping power

determination and

in-vivo

range verification

Speaker: K. Parodi (Germany)

SP-0106

15:10 > Mechanisms and Models of Particle Relative Biological Effectiveness

(RBE)

Speaker: D.J. Carlson (USA)

SP-0107

15:35 > New horizons in radiobiology: from Relative Biological Effectiveness to

“new biology”

Speaker: M. Durante (Italy)

SP-0108